Profit taking related to: a) 12 months since re-listing after IPO; b) +55M shares out of escrow. These factors were always bound to put some short term downwards pressure on the share price. I think this could go on for a couple of weeks until commencement of clinical trials in US. Be patient.
RAP charting, page-4349
-
- There are more pages in this discussion • 4,077 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)